期刊文献+

胃底贲门癌术后腹腔温热灌注化疗效果观察 被引量:1

Effect of intraperitoneal hyperthermic perfusion chemotherapy in post operative gastric fundus cardiac carcinoma
下载PDF
导出
摘要 目的 探讨胃底贲门癌术后腹腔温热灌注化疗对胃底贲门癌术后腹膜转移和生存率的影响。方法 胃底贲门癌患者对照组 2 5例单纯手术 ,化疗组 4 6例手术加术后腹腔温热灌注化疗。结果 化疗组 2年及 3年生存率高于对照组 ,腹腔 2年及 3年复发率低于对照组。结论 胃底贲门癌术后腹腔温热灌注化疗 ,对于防治肿瘤腹膜转移、提高患者生存率有重要意义。 Objective To analyze the effect of intr ap eritoneal hyperthermic perfusion chemotherapy on metastatic rate and survival ra te of postoperative gastric fundus cardiac carcinoma. Methods Pat ients with gastric fundus cardiac carcinoma were divided randomly into control group a nd study group. In total 71 cases, 25 cases were treated by operation as contro l group. 46 cases received intraperitoneal hyperthermic perfusion chemotherapy p ostoperatively as study group. Results The peritoneal recurrence r ate of 2 and 3 years in study group was much lower than that of control group, 2 and 3 years survival rate in study group was higher than that of control grou p. Conclusion Intraperitoneal hyperthermic perfusion chemotherap y in postoperative gastric fundus cardiac carcinoma may be effect on preventing the peritoneal metastasis and improving the survival rate.
出处 《医师进修杂志(外科版)》 2005年第2期17-18,共2页
关键词 胃底贲门癌 腹腔温热灌注化疗 术后 对照组 生存率 效果观察 患者 结论 重要意义 目的 Gastric fundus cardiac carcinoma Operation I ntraperitoneal hyperthermic perfusion chemotherapy
  • 相关文献

参考文献3

二级参考文献23

  • 1朱正纲,尹浩然,林言箴.胃肠道癌术后腹腔内温热灌注疗法的临床意义[J].普外临床,1995,10(2):73-75. 被引量:15
  • 2Sugarbaker PH, Jablonski KA. Prognosis features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg, 1995, 221: 124.
  • 3Sugarbaker PH, Averback AM, Jacquet D, et al.Hyperthermic intraoperative intraperitoneal chemotherapy with mitomycin C. Onoclogy, 1997,Surgical technology international, v. 245.
  • 4Yonemura Y, Fujimura T, Mishimura G, et al.Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surcgery, 1996, 119: 437.
  • 5Fujimoto S, Makoto T, Endoh F, et al. Prevention of peritoneal recurrence in gastric cancer by the chemohyperthermic peritoneal perfusion. First International Gastric Cancer Congress. Kyoto, 1995:1655.
  • 6Los G, van Vugt MJH, Pinedo HM. Response of peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer, 1989, 69: 235.
  • 7Hananel N, Gordon PH, FRCSC, et al. Effect of 5-flurouracil and leucovorin on the integrity of colonic anastomoses in the rats. Dis Colon Rectum, 1995, 38: 886.
  • 8Kern W, Braess J, Samel S, et al. Parmacokinetics of cisplatin and its impact on nephrotoxicity during intraoperative hyperthermic peritoneal lavrage in patients with locally advanced gastric cancer. 2nd International Gastric Cancer Congress, 1997: 1387.
  • 9Fujimura T, Yonemura Y, Muraoka K, et al.Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastriccancer. World J Surg, 1994, 18: 150.
  • 10Giny FN, Carry PY, Sayag AC, et al. Tolerance of intraperitoneal chemohyperthermia with MMC: In vivo study in dogs. Int J Hyperthermia,1992. 8: 659.

共引文献31

同被引文献8

  • 1张秋霞.泰素帝、草酸铂联合氟脲嘧啶/亚叶酸钙方案治疗晚期胃癌临床观察[J].河北医药,2006,28(9):833-833. 被引量:2
  • 2F ujimoto S, Takahashi M, Mutou T, et al. Successful intraperitoneal hyper- thermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer, 1999, 85: 529- 534.
  • 3Hirose K, Katayama K, Iida A, et al. Efficacy of continuous hyperthennic peritoneal peffusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer evaluation by multivariate regression analysis. Oncology, 1999,57: 106-114.
  • 4Sugarbaker PH, Cunliffe WJ, Belliveau J, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical trearment of gastroimestinal cancer. Semin Oncol, 1989, 16: 83-97.
  • 5Sugarbaker PH. Observations concenning cancer spread within the perioneal cavity and concepts supporting and ordered pathophysiolgy. In Sugarbaker PH. Peritoneal Carcinomatosis : Principles of Massachusetts: Kluwer Academic Publisher. 79-100.
  • 6Mechanisms of the information of pertoneal dissemination; Principles of the treatment of pertoneal dissemination; Treatment options for pertoneal dissemination with chemotheraphy; Hyperthemo-chemotherapy for teatment of pertoneal carcinomatosis. In: Yonemura Y, eds. Pertoneal dissemination-molecular mechanisms and the latest therapy. Japan,Maeda Shoten Co,Ltd Kanazawa, 1998.1-46,175-190,191-200,237-258.
  • 7韩晓燕,卫洪波,连建学,张练,娄朝轩,汪雁明.5-氟尿嘧啶不同给药途径的药代动力学研究和临床应用[J].中国新药杂志,1999,8(1):20-23. 被引量:38
  • 8朱正纲,李琛,杨秋蒙,张俊,刘炳亚,尹浩然,林言箴.术中腹腔内温热化疗对胃肠道吻合口愈合影响的研究[J].中华胃肠外科杂志,2001,4(2):99-102. 被引量:12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部